2 results match your criteria: "1 Touro University California College of Pharmacy[Affiliation]"
Value Frameworks for the Patient-Provider Interaction: A Comparison of the ASCO Value Framework Versus NCCN Evidence Blocks in Determining Value in Oncology.
J Manag Care Spec Pharm
June 2017
2 Touro University California College of Pharmacy, Vallejo, California.
Background: To address the rising concern about oncology drug costs, the American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN) recently developed unique tools to help providers and patients make informed decisions about the value of an anticancer regimen. The ASCO Value Framework (AVF) allows users to generate a net health benefit (NHB) score along with drug acquisition costs for oncology regimens that have been compared in a prospective randomized clinical trial. In contrast, the NCCN Evidence Blocks (NEB) derives ratings from an expert panel assessment in the categories of efficacy, safety, quality and consistency of evidence, and affordability.
View Article and Find Full Text PDFMedication Regimen Complexity and A1C Goal Attainment in Underserved Adults With Type 2 Diabetes.
Ann Pharmacother
February 2017
1 Touro University California College of Pharmacy, Vallejo, CA, USA.
Article Synopsis
- From 2009 to 2012, over half of American adults with diabetes had difficulty achieving optimal blood sugar control, with complexity of medication regimens potentially impacting this.
- The study aimed to determine if a higher medication regimen complexity index (MRCI) led to lower achievement of the A1C goal of <7.0% in a largely Hispanic population with type 2 diabetes.
- Results showed that higher diabetes-specific MRCI was linked to poorer glycemic control, suggesting that simplifying medication regimens could help patients meet treatment goals.